Journal Club – Safety & Efficacy Review of IPX203

This Journal Club (JC) will review the RISE-PD trial, reviewing the efficacy and safety of IPX203 in comparison with IR CD-LD in patients.

This JC is a unique opportunity to dig in to the data and better understand a treatment anticipated to be a gamechanger.

Please register below and we will reach out with a reminder in July to be sure it is on your calendar.